Skip to content
healthcare.dev

Oxcarbazepine

NDC 50742-612, Oxcarbazepine, tablet, extended release, from Ingenus Pharmaceuticals, LLC.

Product NDC
50742-612
Status
Listed
Labeler
Ingenus Pharmaceuticals, LLC
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215796
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50742-612 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OXCARBAZEPINE300 mg/1

Pharmacologic classes

Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
50742-612-0150742061201100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50742-612-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/70798ca9-0eda-49c0-8a7c-b775b6ae3d69
  • NADAC price for package 50742061201

    GET /v1/drugs/nadac/50742061201

Use it

Look up 50742-612 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50742-612 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50742-612. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.